Circulating Apelin-17 and Elabela Levels as Predictive Biomarkers of Neurodegeneration and Cognitive Decline in Alzheimer’s Disease

Shaimaa Imad Ali; Alabbas Majeed

doi:10.47419/bjbabs.v6i3.407

Authors

Shaimaa Imad Ali Department of Chemistry, College of science, Al-Nahrain University, Jadriya, Baghdad, Iraq https://orcid.org/0000-0001-6799-8053
Alabbas Majeed Department of Molecular and Medical Biotechnology, College of Biotechnology, Al-Nahrain University, Baghdad, Iraq. https://orcid.org/0009-0008-2609-1840

DOI:

https://doi.org/10.47419/bjbabs.v6i3.407

Keywords:

Alzheimer’s disease, Apelin-17 , Elabela, IL-6, TNF-α

Abstract

Background: Alzheimer’s disease is characterized by progressive neurodegeneration and cognitive decline. Early diagnosis and monitoring are critical but remain challenging. Apelin-17 and Elabela, endogenous ligands of the apelin receptor (APJ), have emerged as neuroprotective peptides with potential biomarker utility. Objective: To evaluate circulating Apelin-17 and Elabela levels as predictive biomarkers of neurodegeneration and cognitive impairment in Alzheimer’s disease. Methods: We measured plasma Apelin-17 and Elabela in 60 Alzheimer’s disease patients and 60 cognitively normal controls. Correlations with cognitive scores, CSF AD biomarkers (Aβ42, total tau, phosphorylated tau), inflammatory markers (IL-6, TNF-α, CRP), and MRI volumetric data were assessed. A subset (n=30) was followed longitudinally for 12 months. Results: Alzheimer’s disease patients showed significantly reduced Apelin-17 (48.7 ± 15.3 pg/mL vs. 82.1 ± 20.4 pg/mL) and Elabela levels (31.5 ± 9.8 pg/mL vs. 57.3 ± 14.1 pg/mL; p < 0.001 for both). Peptide levels correlated positively with MMSE and specific cognitive domains and inversely with CSF tau, inflammatory markers, and brain atrophy (hippocampus, entorhinal, parietal cortex). Baseline peptides predicted 12-month cognitive decline and hippocampal volume loss. Combined biomarker models including Apelin-17, Elabela, and classical markers improved diagnostic accuracy (AUC=0.93). Conclusion: Circulating Apelin-17 and Elabela are promising predictive biomarkers for neurodegeneration and cognitive decline in Alzheimer’s disease, reflecting multiple pathological processes. They hold potential for early diagnosis, monitoring, and therapeutic targeting.

Metrics

Metrics Loading ...

Downloads

Download data is not yet available.

References

Contador. I, B, Del Ser. T, Llamas-Velasco. S, Villarejo-Galende. A, Benito-León. J, Bermejo-Pareja F. Charting Alzheimer’s disease and dementia: epidemiological insights, risk factors and prevention pathways. J. Clin. Med. 2024 ;13(14):4100. doi: 10.3390/jcm13144100.

Gyimesi. M, Okolicsanyi. RK, Haupt LM. Beyond amyloid and tau: rethinking Alzheimer’s disease through less explored avenues. Open Biology. 2024;14(6):240035.https://doi.org/10.1098/rsob.240035.

Alshaebi. F, Sciortino. A, Kayed. R. The role of glial cell senescence in Alzheimer's disease. J. Neurochem. 2025;169(3):70051. https://doi.org/10.1111/jnc.70051.

Kivipelto. M, Helkala. EL, Laakso. MP, Hänninen. T, Hallikainen. M, Alhainen. K, et. al. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population-based study. Bmj. 2001;322(7300): 1447-51. https://doi.org/10.1136/bmj.322.7300.1447.

Liu RM. Aging, cellular senescence, and Alzheimer’s disease. Int. J. Mol. Sci. 2022 ;23(4):1989.https://doi.org/10.3390/ijms23041989.

Hampel H, Hardy J, Blennow K, Chen C, Perry G, Kim SH, et al. The amyloid-β pathway in Alzheimer’s disease. Molecular psychiatry. 2021 ;26(10):5481-503. https://doi.org/10.1038/s41380-021-01249-0.

Nasb M, Tao W, Chen N. Alzheimer's disease puzzle: delving into pathogenesis hypotheses. Aging and Disease. 2024 ;15(1):43. doi: 10.14336/AD.2023.0608.

Sehar. U, Rawat. P, Reddy. AP, Kopel. J, Reddy. PH. Amyloid beta in aging and Alzheimer’s disease. Int. J. Mol. Sci. 2022 ;23(21):12924. https://doi.org/10.3390/ijms232112924.

Bigi A, Cascella R, Chiti F, Cecchi C. Amyloid fibrils act as a reservoir of soluble oligomers, the main culprits in protein deposition diseases. BioEssays. 2022;44(11):2200086. https://doi.org/10.1002/bies.202200086.

Akpoghelie PO, Edo GI, Ali SI, Kasar KA, Zainulabdeen K, Mohammed AA, et al. Effect of processing on the microbiological, proximate, antinutritional and mineral profile of selected yellow cassava varieties and sorghum malt as potential raw materials for alcoholic beverage production. Beverage Plant Research. 2024;4(1)55-57.doi: 10.48130/bpr-0024-0022.

Joseph B, Thomas S, Sen N, Paschold A, Binder WH, Kumar S. Bioinspired synthetic polymers-based inhibitors of Alzheimer's amyloid-β peptide aggregation. Polym. Chem. 2023;14(4):392-411. https://doi.org/10.1039/D2PY01217K.

Pradeepkiran JA, Baig J, Islam MA, Kshirsagar S, Reddy PH. Amyloid-β and phosphorylated tau are the key biomarkers and predictors of Alzheimer’s disease. Aging Dis. 2024;16(2):658.doi: 10.14336/AD.2024.0286.

Wang M, Yan C, Li X, Yang T, Wu S, Liu Q, Luo Q, Zhou F. Non-invasive modulation of meningeal lymphatics ameliorates ageing and Alzheimer’s disease-associated pathology and cognition in mice. Nat. Commun. 2024;15(1):1453. https://doi.org/10.1016/j.neuropharm.2019.107960.

Ali LI, Ali SI, Khaleel FM, Hassan WS, Hussein KA, et al. Evaluation of Apelin, Elabela, and Certain Biomarkers in Patients with Metabolic Disease Associated with Obesity. Diyala Journal of Medicine. 2025 ;28(2):1-2. https://doi.org/10.26505/djm.v28i2.1187.

Ali SE, Khaleel FM. Assessing the Activity of Renin and GST in the Serum of Ladies Suffering from Polycystic Ovary Syndrome and COVID-19 to Predict the Danger of Cardiac Disease. Baghdad Sci. J. 2023, 20(3): 986-993 https://dx.doi.org/10.21123/bsj.

Chen J, Zhu Z, Xu Y. Signs of Alzheimer’s Disease: Tied to Aging. Int. J. Mol. Sci. 2025 ;26(11):4974. https://doi.org/10.1007/s12031-019-01264-7.

Luo H, Han L, Xu J. Apelin/APJ system: a novel promising target for neurodegenerative diseases. J. Cell. Physiol. 2020 ;235(2):638-57. https://doi.org/10.1002/jcp.29001.

Chen J, Zhu Z, Xu Y. Signs of Alzheimer’s Disease: Tied to Aging. International Journal of Molecular Sciences. 2025 ;26(11):4974.https://doi.org/10.3390/ijms26114974.

Wang X, Zhang L, Li P, Zheng Y, Yang Y, Ji S. Apelin/APJ system in inflammation. International Immunopharmacology. 2022 ;10(9):108-822.https://doi.org/10.1016/j.intimp.2022.108822.

Xu J, Chen L, Jiang Z, Li L. Biological functions of Elabela, a novel endogenous ligand of APJ receptor. Journal of cellular physiology. 2018 ;233(9):6472-82.https://doi.org/10.1002/jcp.26492.

Samant NP, Gupta GL. Avicularin attenuates memory impairment in rats with amyloid beta-induced Alzheimer’s disease. Neurotoxicity research. 2022 ;40(1):140-53. https://doi.org/10.1007/s12640-021-00467-2.

Balestrieri JV, Nonato MB, Gheler L, Prandini MN. Structural volume of hippocampus and Alzheimer’s disease. Revista da Associação Médica Brasileira. 2020;66(4):512-5. https://doi.org/10.1590/1806-9282.66.4.512 .

Yavuz, M. M., & Erbaş, O. (2022). Elabela peptide ameliorates beta-amyloid-induced cognitive deficits in rats by reducing oxidative stress and apoptosis. Peptides, 150, 170717. https://doi.org/10.1016/j.peptides.2021.170717.

Bian X, Wang Q, Wang Y, Lou S. The function of previously unappreciated exerkines secreted by muscle in regulation of neurodegenerative diseases. Frontiers in Molecular Neuroscience. 2024; 16:1305208. https://doi.org/10.3389/fnmol.2023.1305208.

Luo H, Xiang Y, Qu X, Liu H, Liu C, Li G, Han L, Qin X. Apelin-13 suppresses neuroinflammation against cognitive deficit in a streptozotocin-induced rat model of Alzheimer’s disease through activation of BDNF-TrkB signaling pathway. Frontiers in Pharmacology. 2019 Apr 16; 10:395. https://doi.org/10.3389/fphar.2019.00395.